Daily Stock Market Reports

Cancer diagnostics maker Accustem files for Nasdaq uplisting, $11M offering


Initial public offering hologram, night panoramic city view of Bangkok. The financial center for multinational corporations in Asia. The concept of boosting the growth by IPO process. Double exposure.

2d illustrations and photos/iStock via Getty Images

Oncology diagnostics developer Accustem Sciences (OTCQB:ACUT) has filed to uplist its shares to Nasdaq and raise $11M.

Accustem said in a filing that it was looking to offer 1.5M shares at the



Read More: Cancer diagnostics maker Accustem files for Nasdaq uplisting, $11M offering

You might also like